SARS-CoV-2 triggered a high prevalence of pneumonia rather than upper respiratory symptoms in infected patients, which was consistent with the results of the current study, due to the dense distribution of angiotensin-converting enzyme 2 (ACE2), a cellular receptor, in the lower respiratory tract. Here, ACE2 is linked to pneumonia.